info icon

Carcinoma in situ of bronchus and lung

CD2_INSITU_BRONCHUSLUNG

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_BRONCHUS_LUNG
511876

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D02.2&
  • Hospital discharge: ICD-9 2312
  • Cause of death: ICD-10 D02.2&
  • Cause of death: ICD-9 2312
  • Cancer registry: Topography ICD-O-3 C34
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 2

3 out of 7 registries used, show all original rules.

44

4. Check minimum number of events

None

44

5. Include endpoints

None

44

6. Filter based on genotype QC (FinnGen only)

44

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D02
Name in latin
Carcinoma in situ mammae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 44 16 28
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 69.10 68.65 69.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
15
30
7.07
7.84
1.5
1.1
—
—
—
0
0
28
126
4.36
5.34
2.9
2.3
—
—
—
0
0
12
28
5.52
5.20
1.3
1.3
—
—
—
0
0
15
47
4.33
4.56
7.7
5.4
3.6
95.2
ug/l
0.54
15
41
12
35
4.34
3.94
1.5
1.2
—
—
—
0
0
30
164
3.61
3.89
10.8
8.5
1.3
1.3
inr
—
5
57
29
161
3.35
3.56
6.4
4.9
35.1
34.4
g/l
0.37
29
152
14
53
3.41
3.16
1.7
2.0
—
—
—
0
0
5
5
11.03
3.05
2.6
2.8
—
—
—
0
0
10
31
3.88
2.98
4.1
4.2
—
—
—
0
0
22
115
2.83
2.82
3.5
2.1
—
—
—
0
0
5
6
9.18
2.82
2.0
1.5
—
—
—
0
0
32
213
2.84
2.45
9.8
12.2
4.6
4.4
e9/l
0.11
32
183
8
23
4.01
2.40
4.8
9.7
27.6
24.8
mmol/l
—
8
23
31
205
2.73
2.37
11.9
7.1
19.8
11.3
umol/l
0.45
31
194
21
116
2.55
2.32
3.7
5.2
7.4
7.4
ph
—
6
23
22
127
2.46
2.19
3.6
4.4
—
—
—
0
0
11
45
2.93
2.12
1.1
1.5
—
—
—
0
0
7
21
3.76
2.06
2.1
2.8
—
—
—
0
0
25
165
2.19
1.71
4.1
5.1
62.5
59.0
%
0.75
25
153
20
121
2.20
1.70
3.4
4.6
—
—
—
0
0
24
159
2.12
1.60
4.7
4.9
0.7
0.6
%
0.48
24
144
5
16
3.38
1.48
9.8
4.4
0.8
0.9
%
—
5
16
24
164
2.02
1.42
4.7
5.3
9.5
8.6
%
0.67
24
151
24
164
2.02
1.42
4.5
5.0
3.2
2.4
%
1.17
24
151
14
79
2.13
1.37
4.1
6.4
—
—
—
0
0
6
24
2.73
1.35
1.2
1.6
—
—
—
0
0
6
25
2.61
1.29
18.7
7.8
—
—
—
0
0
15
90
2.01
1.24
4.9
3.2
87.2
84.7
%
0.20
15
90
30
229
1.97
1.23
8.4
5.2
7.5
6.9
mmol/l
1.17
30
217
8
39
2.28
1.23
2.3
4.5
—
—
—
0
0
9
45
2.25
1.14
1.6
1.1
—
—
—
0
0
32
255
1.93
1.09
5.2
4.9
—
—
—
0
0
8
43
2.05
0.94
9.6
11.1
113.9
119.2
g/l
—
8
43
6
31
2.08
0.88
9.5
4.9
—
—
—
0
0
8
47
1.86
0.86
2.4
7.0
1.0
1.1
mmol/l
—
8
47
9
52
1.92
0.83
15.9
9.9
3.9
1.4
mmol/l
—
9
42
20
148
1.64
0.80
2.6
4.0
573.6
73.4
e6/l
0.43
15
112
0
19
0.00
0.62
0.0
6.9
—
—
—
0
0
0
21
0.00
0.62
0.0
6.7
—
—
—
0
0
11
74
1.65
0.60
7.5
3.1
12.9
157.4
ng/l
0.96
11
62
6
37
1.72
0.58
16.0
12.1
—
—
—
0
0
6
37
1.72
0.58
5.2
5.7
1.2
1.2
mmol/l
—
6
31
17
130
1.50
0.55
2.8
2.8
109.1
157.5
ug/l
0.59
17
118
15
115
1.46
0.47
2.5
2.9
—
—
—
0
0
32
352
0.67
0.46
5.5
5.7
2.4
2.5
mmol/l
0.51
27
315
20
163
1.42
0.46
11.7
12.3
0.0
0.0
e9/l
0.47
14
133
8
59
1.43
0.44
1.8
2.8
2.4
2.3
g/l
—
8
50
5
32
1.63
0.44
1.2
8.3
9.1
11.1
mmol/l
—
5
32
0
15
0.00
0.42
0.0
1.0
—
—
—
0
0
20
165
1.39
0.42
2.3
1.9
108.1
94.6
pmol/l
0.59
14
87
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
26
294
0.72
0.41
33.9
17.8
36.6
39.3
%
0.48
16
183
0
18
0.00
0.41
0.0
1.8
—
—
—
0
0
5
35
1.48
0.41
2.6
1.8
441.0
328.4
nmol/l
—
5
30
31
339
0.71
0.37
5.2
5.1
1.4
1.4
mmol/l
0.11
26
300
31
339
0.71
0.37
5.0
5.1
4.2
4.3
mmol/l
0.20
25
305
11
83
1.43
0.36
1.4
1.3
—
—
—
0
0
6
44
1.42
0.36
1.2
1.7
—
—
—
0
0
7
54
1.35
0.32
2.1
2.1
1.7
1.7
%
—
7
47
8
61
1.38
0.30
1.9
2.8
8.0
13.1
umol/l
—
8
51
30
326
0.75
0.30
4.8
4.5
1.2
1.3
mmol/l
0.43
24
289
13
105
1.34
0.29
6.8
4.7
—
—
—
0
0
36
338
1.36
0.24
7.0
6.7
42.2
41.7
mmol/mol
0.11
31
308
5
38
1.36
0.24
2.2
2.7
2.6
7.9
ug/l
—
5
33
25
273
0.80
0.22
46.9
22.7
328.6
331.7
g/l
0.93
25
273
0
10
0.00
0.21
0.0
3.4
—
4.0
—
0
10
0
10
0.00
0.21
0.0
3.4
—
107.8
—
0
10
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
2.9
—
126.7
—
0
8
39
374
1.38
0.18
37.0
20.2
87.2
84.8
umol/l
0.19
39
374
38
363
1.34
0.17
28.8
16.5
—
—
—
0
0
9
108
0.79
0.15
4.4
3.4
—
—
—
0
0
5
43
1.18
0.10
4.8
3.7
—
—
—
0
0
18
194
0.88
0.09
6.5
4.6
0.0
0.0
estimate
—
6
39
39
378
1.28
0.09
35.7
19.7
138.7
139.8
mmol/l
1.09
39
365
39
381
1.21
0.09
35.7
19.6
4.0
4.0
mmol/l
0.32
39
368
13
139
0.91
0.04
4.3
3.9
0.7
10.6
mg/mmol
—
6
90
11
103
1.09
0.02
4.5
6.2
—
—
—
0
0
28
275
1.05
0.00
5.9
4.2
—
—
—
0
0
12
116
1.05
0.00
3.9
4.7
—
—
—
0
0
13
126
1.05
0.00
3.2
3.2
7.9
76.2
mg/l
—
6
85
19
195
0.95
0.00
6.2
4.7
0.0
0.0
estimate
—
5
35
19
194
0.96
0.00
9.3
6.4
0.0
0.0
estimate
—
6
36
13
128
1.02
0.00
3.2
3.1
8.0
7.8
mmol/l
—
7
105
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
371.5
—
0
6
0
6
0.00
0.00
0.0
1.0
—
3.3
—
0
6
39
383
1.16
0.00
43.6
24.9
242.2
237.5
e9/l
0.19
39
372
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
39
383
1.16
0.00
43.4
24.9
4.3
4.5
e12/l
0.77
39
370
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
39
383
1.16
0.00
43.6
25.0
7.3
6.7
e9/l
1.14
39
370
39
383
1.16
0.00
45.1
25.0
131.4
134.5
g/l
0.63
39
375
14
140
1.00
0.00
4.9
3.5
—
—
—
0
0
39
383
1.16
0.00
43.3
24.8
30.7
30.5
pg
0.33
39
375
0
5
0.00
0.00
0.0
1.2
—
5.4
—
0
5
39
383
1.16
0.00
43.4
24.9
92.5
91.7
fl
0.49
39
375
0
6
0.00
0.00
0.0
1.3
—
315.5
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
4.2
—
20.0
—
0
5
0
9
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_BRONCHUSLUNG – Carcinoma in situ of bronchus and lung

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).